
LabNote
LabNote is complete research note & data management solution for BT & NT (Bio Tech & Nano Tech) researchers and organizations.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | KRW2.8b | Seed | |
Total Funding | 000k |
Related Content
LabNote operates in the digital transformation sector, providing a specialized platform for research in biology, nanotechnology, chemistry, and pharmaceuticals. The company serves corporate customers, government entities, and research institutions by offering a comprehensive solution for managing and sharing research data. LabNote's business model revolves around subscription-based services, where clients pay for access to the platform's features, including unlimited data capacity, custom checks for labs, and efficient collaboration tools. The platform is designed to streamline experimental processes, record functions, and research results, making it easier for researchers to document and share their findings. LabNote generates revenue through subscription fees and potentially through additional services like custom integrations and premium support. The market for LabNote includes biotech firms, academic institutions, and government research agencies, all of which require robust data management solutions to enhance their research capabilities.
Keywords: digital transformation, research data management, biotech, nanotechnology, chemistry, pharmaceuticals, collaboration tools, subscription model, custom lab checks, government research.